Delivery Order SPE2DB22D3301-SPE2DB24FZ3SZ

Award Date 8/29/24
Potential Completion Date 9/20/24
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RHOGAM ULTRA-FILTERED PLUS SYRS, a pharmaceutical product. The delivery order has a ceiling value of $1,969.36 and is a firm fixed price contract. The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of RHOGAM ULTRA-FILTERED PLUS SYRS. The contract has a firm fixed price and a ceiling value of $1,364.39. It is not set aside for any specific business type. The contract has an ultimate completion date of August 29, 2024. AmerisourceBergen Drug Corp, through its Corporate Office division, is a major supplier of pharmaceutical and medical products to various federal...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RHOGAM ULTRA-FILTERED PLUS SYRS, a pharmaceutical product. The contract has a firm fixed price of $1,138.25 and a completion date of July 24, 2025. It is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award, valued at $1,180.20, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of RHOGAM ULTRA-FILTERED PLUS SYRS, a pharmaceutical product, with a completion date of December 4, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through November 2026....
This federal contract award is for the delivery of RHOGAM ULTRA-FILTERED PLUS SYRS, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $2,360.40, and has an ultimate completion date of July 23, 2024....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of pharmaceutical products and medical supplies, including Rho(D) Immune Globulin Intravenous (Human) RHOGAM ULTRA-FILTERED PLUS SYRS. The contract has a ceiling value of $2,360.40 and a completion date of May 20, 2024. The contract is a firm fixed price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp is a...
This federal contract award is for the delivery of RHOGAM ULTRA-FILTERED PLUS SYRS to the Defense Logistics Agency (DLA). The award, valued at $6,821.95, was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 1, 2024. The contract is not designated with a set-aside requirement, indicating open competition....
The federal contract award, with ID SPE2DB20D3103/SPE2DB22FP2V7, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,590.90 firm fixed-price delivery order is for the supply of RHOGAM ULTRA-FILTERED PLUS SYRS, a medical product, with an ultimate completion date of August 12, 2022. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The contract, valued at $1,180.20, is for the supply of Rho(D) Immune Globulin (Human) - RhoGAM Ultra-Filtered Plus Syringes, a specialty pharmaceutical product used to prevent Rh immunization. The contract is a firm fixed price delivery order with an ultimate completion date of April...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,731.80, is a Firm Fixed Price Delivery Order for the supply of Rhogam Ultra-Filtered Plus Syrs, a specialized pharmaceutical product. The contract is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FZ3SZ
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division, for the supply of RHOGAM ULTRA-FILTERED PLUS SYRS, a pharmaceutical product. The contract has a firm fixed price ceiling value of $2,360.40 and an ultimate completion date of September 20, 2024. The contract is not a set-aside award. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of medical commodities to support military treatment programs and facilities worldwide.

Generated 11/28/24, 9:11 AM